Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical Sciences Division News

Department of Pharmacology research leads to FDA approval for new NPC treatment

A Department of Pharmacology start-up company has received approval from the US Food and Drug Administration (FDA) for a new treatment for the rare lysosomal storage disorder Niemann-Pick Disease Type C (NPC) in both adults and children.

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.

Study of menstrual tracking app usage highlights potential role in improving access to reproductive health services

A new study by researchers in the UK and Denmark, published in Digital Health, provides the first publicly accessible analysis of global downloads for menstrual tracking apps.

Professor Anthony Harnden appointed as the new Chair of the Medicine and Healthcare products Regulatory Agency (MHRA)

Professor Anthony Harnden, of Nuffield Department of Primary Care Health Sciences, University of Oxford, and former Deputy Chair of the Joint Committee on Vaccination and Immunisation (JCVI), has been appointed Chair of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

Four Oxford academics receive ERC Synergy Grants to address complex scientific problems

Four Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants foster interdisciplinary and international collaboration between outstanding researchers, enabling them to combine their expertise, knowledge, and resources to push the boundaries of scientific discovery.